Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 2;7(1):1077.
doi: 10.1038/s42003-024-06795-1.

Shared genetic architecture between gastro-esophageal reflux disease, asthma, and allergic diseases

Affiliations

Shared genetic architecture between gastro-esophageal reflux disease, asthma, and allergic diseases

Tong Gong et al. Commun Biol. .

Abstract

The aim is to investigate the evidence for shared genetic architecture between each of asthma, allergic rhinitis and eczema with gastro-esophageal reflux disease (GERD). Structural equation models (SEM) and polygenic risk score (PRS) analyses are applied to three Swedish twin cohorts (n = 46,582) and reveal a modest genetic correlation between GERD and asthma of 0.18 and bidirectional PRS and phenotypic associations ranging between OR 1.09-1.14 and no correlations for eczema and allergic rhinitis. Linkage disequilibrium score regression is applied to summary statistics of recently published GERD and asthma/allergic disease genome wide association studies and reveals a genetic correlation of 0.48 for asthma and GERD, and Genomic SEM supports a single latent factor. A gene-/gene-set analysis using MAGMA reveals six pleiotropic genes (two at 12q13.2) associated with asthma and GERD. This study provides evidence that there is a common genetic architecture unique to asthma and GERD that may explain comorbidity and requires further investigation.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare except for Professor Nicholas Talley (NJT). NJTs involvement is all outside the submitted work: Norgine (2021)(IBS interest group), personal fees from Allakos (gastroduodenal eosinophilic disease) (2021), twoXAR Viscera Labs, (USA 2021) (IBS-diarrhea), IsoThrive (2021) (esophageal microbiome), BluMaiden (microbiome advisory board) (2021), Rose Pharma (IBS) (2021), Intrinsic Medicine (2022) (human milk oligosaccharide), Comvita Mānuka Honey (2021) (digestive health), Astra Zeneca (2022). In addition, Dr. Talley has a patent Nepean Dyspepsia Index (NDI) 1998, a patent Licensing Questionnaires Talley Bowel Disease Questionnaire licensed to Mayo/Talley, “Diagnostic marker for functional gastrointestinal disorders” Australian Provisional Patent Application 2021901692, ”Methods and compositions for treating age-related neurodegenerative disease associated with dysbiosis” US Application No. 63/537,725.

Figures

Fig. 1
Fig. 1. Associations between phenotypes and polygenic risk scores for GERD with eczema, allergic rhinitis, and asthma in Swedish twins.
The associations being presented in odds ratios (OR) are statistically significant when the horizontal line of the confidence interval (error bars) does not cross the vertical gray line at the value 1.
Fig. 2
Fig. 2. Common factor (F1) model for all traits as estimated in Genomic SEM.
F1 is a latent common genetic factor of the genetic components of five GWAS phenotypes, i.e., adult-onset and childhood-onset asthma, allergic rhinitis, eczema, and GERD. The loading of adult-onset asthma was fixed to 1 for model identification purposes. One-headed arrows showed path regression estimates from the independent variable to the dependent variables. Standardized path estimates are given with their standard error in parentheses. The latent u variables with circular arrows reflect the residual variance in the genetic indicators not explained by the common factor.

References

    1. To, T. et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health12, 204 (2012). 10.1186/1471-2458-12-204 - DOI - PMC - PubMed
    1. Broers, C., Tack, J. & Pauwels, A. Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease. Aliment Pharm. Ther.47, 176–191 (2018).10.1111/apt.14416 - DOI - PubMed
    1. Vakil, N. Disease definition, clinical manifestations, epidemiology and natural history of GERD. Best. Pract. Res. Clin. Gastroenterol.24, 759–764 (2010). 10.1016/j.bpg.2010.09.009 - DOI - PubMed
    1. Kim, S. Y., Min, C., Oh, D. J. & Choi, H. G. Bidirectional association between GERD and asthma: two longitudinal follow-up studies using a national sample cohort. J. Allergy Clin. Immunol. Pr.8, 1005–1013 e1009 (2020).10.1016/j.jaip.2019.10.043 - DOI - PubMed
    1. Althoff, M., Ghincea, A., Wood, L., Holguin, F. & Sharma, S. Asthma and three colinear comorbidities: obesity, OSA and GERD. J. Allergy Clin. Immunol. Pr.9, 3877–3884 (2021).10.1016/j.jaip.2021.09.003 - DOI - PMC - PubMed

Publication types